Navigation Links
PAREXEL Reports Fourth Quarter and Fiscal Year 2008 Financial Results
Date:8/6/2008

(34)

Total costs and expenses 1,076,304 860 1,077,164 860,538

Income from operations 86,666 (860) 85,806 57,566

Other income (expense) (1,129) (1,129) 1,968

Income before income taxes 85,537 (860) 84,677 59,534

Provision for income taxes 20,026 12,383 ( c ) 32,409 22,277

Effective tax rate 23.4% 38.3% 37.4%

Minority interest expense

(benefit) 871 871 (32)

Net income $64,640 $(13,243) $51,397 $37,289

Earnings per common share:

Basic $1.16 $0.92 $0.68

Diluted $1.12 $0.89 $0.66

Shares used in computing

earnings per common share:

Basic 55,896 55,896 54,633

Diluted 57,461 57,461 56,216

(a) Fiscal Year 2007 numbers have been adjusted to reflect Fiscal Year

2008 presentation. Certain direct costs have been moved to selling,

general and administrative to ensure consistency among all business

segments.

(b) Represents a change in assumptions in restructuring reserves mainly

related to facilities in the U.K.

( c ) Represents a non-U.S. net tax benefit of $4 million, related in part

to a reduction in German tax rates, and an $11.1 million reversal of

certain U.S. tax valuation reserves, which were offset by $2.4

million in adjustments to the Netherlands tax reserves, and a $0.3

million tax adjustment related to the restructuring benefit.

PAREXEL International Corporation

Segment Information


'/>"/>

SOURCE PAREXEL International Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology technology :

1. PAREXEL Promotes Dr. Mark A. Goldberg to Chief Operating Officer
2. PAREXEL Announces Date of Fourth Quarter and Fiscal Year 2008 Earnings Release and Conference Call
3. PAREXEL International Updates Earnings Guidance in Conjunction with Its Investor Day
4. PAREXEL Expands Global Clinical Logistics Capabilities
5. Parexel Invites Public to Listen to Live Webcast of Its Investor Day June 25, 2008
6. PAREXEL Enhances Early Phase Clinical Development Offering for Central Nervous System Studies
7. PAREXEL Experts to Address Key Industry Topics at the Drug Information Association 44th Annual Meeting
8. PAREXEL Reaches Agreement To Acquire ClinPhone
9. PAREXEL International to Present at Goldman Sachs 29th Annual Global Healthcare Conference
10. PAREXEL Product Development and Regulatory Experts to Attend the 2008 BIO International Convention
11. PAREXEL Appoints Leading Biostatistician Dr. Imogene Grimes to Vice President of Data Sciences Strategic Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/20/2013)... Dental decay is the number one ... For Dr. Crisafulli of Crisafulli Dental those statistics are no ... the world and implemented a cavity prevention program developed by ... by up to 74% . The system is ... finally found a solution to dental decay that works,” says ...
(Date:6/19/2013)... IL (PRWEB) June 19, 2013 For ... offers Waterless Bead Baths using metallic beads ... less electricity, and do not require germicides. Yet, the ... and, because the bath is always ready unlike a ... beads create a dry bath, which eliminates the contamination ...
(Date:6/19/2013)... 2013 Research and ... addition of the "Global Biometric Systems ... to their offering.      (Logo: ... protection and old security practises such as ... the growth of biometric technologies in last ...
(Date:6/19/2013)... 19, 2013  Continuing its long history of proven ... Beckman Coulter , Inc. announces the U.S. Food and ... AccuTnI+3 troponin I assay for use on its Access ... on Beckman Coulter,s troponin I test for ... the proven performance to continue providing dependability to laboratories ...
Breaking Biology Technology:Crisafulli Dental Launches Ground Breaking Cavity Prevention Program That Can Lower Decay Rates by 74% 2Cole-Parmer Introduces Eco-Friendly Waterless Bead Baths 2Global Biometric Systems Market Forecast Report - Opportunities to 2018 2Global Biometric Systems Market Forecast Report - Opportunities to 2018 3Beckman Coulter Announces FDA Clearance of New Access AccuTnI+3 Troponin I Assay for the Access 2 Immunoassay System 2Beckman Coulter Announces FDA Clearance of New Access AccuTnI+3 Troponin I Assay for the Access 2 Immunoassay System 3
... ValGenesis, Inc., a world-class provider of Validation Lifecycle ... ValGenesis Suite 2.5 has achieved SAP certification as ... this certified integration status deepens ValGenesis, active and ... SAP Integration and Certification Center (SAP ICC) has ...
... BioLife Solutions , Inc. (OTCBB: BLFS), a leading ... hypothermic storage and cryopreservation freeze ... that TRANSFUSION , the foremost publication in ... has published a peer-reviewed journal article reporting positive ...
... Inspired Engineering at Harvard University have developed a robotic ... specific cell targets within a complex mixture of cell ... cancer cells to self-destruct. Inspired by the mechanics of ... day be used to program immune responses to treat ...
Cached Biology Technology:ValGenesis Suite 2.5 Certified by SAP as Powered by SAP NetWeaver® 2ValGenesis Suite 2.5 Certified by SAP as Powered by SAP NetWeaver® 3Improved Cord Blood Processing Research on BioLife Solutions CryoStor® Published in TRANSFUSION 2Improved Cord Blood Processing Research on BioLife Solutions CryoStor® Published in TRANSFUSION 3Improved Cord Blood Processing Research on BioLife Solutions CryoStor® Published in TRANSFUSION 4Harvard's Wyss Institute develops DNA nanorobot to trigger targeted therapeutic responses 2Harvard's Wyss Institute develops DNA nanorobot to trigger targeted therapeutic responses 3
(Date:6/18/2013)... Obar, Ph.D., Department of Immunology and Infectious Diseases, Montana ... Young Investigator Award for his research on factors affecting ... , Obar earned his B.A. in Microbiology from ... complete his Ph.D. in Microbiology and Immunology from Dartmouth ... research in Edward Usherwood,s laboratory at the Geisel School ...
(Date:6/18/2013)... is estimated that between 5% and 10% of breast ... to say that these tumours are attributable to inherited ... or BRCA2. In patients with these mutations, PARP inhibitors, ... results that make them a new option for personalised ... latest studies indicate that a fraction of these patients ...
(Date:6/18/2013)... that weight gain and increased head size in the first month ... early school age. , The study was led by University of ... children who were born full-term. , The results, published in the ... on 40% of their birthweight in the first four weeks had ... years of age, compared with babies who only put on 15% ...
Breaking Biology News(10 mins):The American Society for Microbiology honors Joshua Obar 2An article in 'Cell' reveals a new resistance mechanism to chemotherapy in breast and ovarian cancer 2IQ link to baby's weight gain in first month 2
... known that excessive text messaging can result in sore thumbs, ... arms and hands. Young adults with symptoms in these parts ... to a study at the Sahlgrenska Academy, University of Gothenburg, ... 56 young adults who text message on a daily basis. ...
... warming whips up more powerful and frequent hurricanes and storms, ... to breed and recover from damage. That,s one of ... of corals in the wake of large climate-driven bleaching and ... recruitment the regrowth of young corals drops sharply ...
... San Jose, California, June 23, 2009 Chronix ... peer-reviewed journal further confirms the potential diagnostic and prognostic ... early stage disease. These DNA fragments, referred to ... in trace amounts during the disease process. Chronix Biomedical ...
Cached Biology News:How to text message and avoid pain 2Coral face 'a stormy future' 2Study shows Chronix technology using serum DNA can identify early presence of disease 2
Request Info...
Polyclonal Antibody to CLAN...
Goat polyclonal to MLH3 ( Abpromise for all tested applications). entrezGeneID: 27030 SwissProtID: Q9UHC1...
Rabbit polyclonal to NMDAR1 e/f/g/h ( Abpromise for all tested applications)....
Biology Products: